𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Hepatic artery infusion chemotherapy for colorectal metastases: A personal experience

✍ Scribed by William L. Donegan

Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
714 KB
Volume
30
Category
Article
ISSN
0022-4790

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A potential role for perioperative hepat
A potential role for perioperative hepatic arterial infusion chemotherapy?
✍ N. Joseph Espat πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 48 KB

The liver is the most common site of distant failure and cause of disease‐related mortality in patients with advanced colon carcinoma. In the study by Sadahiro et al., a randomized controlled study evaluated the effects of prophylactic hepatic arterial infusion chemotherapy for the prevention of liv

Effect of aberrant hepatic arterial anat
Effect of aberrant hepatic arterial anatomy on tumour response to hepatic artery infusion of floxuridine for colorectal liver metastases
✍ D. Burke; S. Earlam; C. Fordy; Mr T. G. Allen-Mersh πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 346 KB πŸ‘ 2 views

Regional hepatic artery infusion of colorectal liver metastases produces the highest reported treatment response. The effect of variation in hepatic artery anatomy on tumour response to regional floxuridine (FUdR) was studied. Aberrant hepatic arterial anatomy occurred in 13 of 74 patients (18 per c

Limited but definite efficacy of prophyl
Limited but definite efficacy of prophylactic hepatic arterial infusion chemotherapy after curative resection of colorectal liver metastases : A randomized study
✍ Takeshi Tono; Yasunori Hasuike; Hiroki Ohzato; Yuichi Takatsuka; Nobuteru Kikkaw πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 96 KB πŸ‘ 2 views

## BACKGROUND. Greater than 50% of patients who undergo curative resection of liver metastases from colorectal carcinoma develop recurrent disease in the residual liver. Although several studies have attempted to use hepatic arterial infusion (HAI) chemotherapy to prevent recurrence, to the authors

Results of pharmacokinetic modulating ch
Results of pharmacokinetic modulating chemotherapy in combination with hepatic arterial 5-fluorouracil infusion and oral UFT after resection of hepatic colorectal metastases
✍ Masato Kusunoki; Hidenori Yanagi; Masafumi Noda; Reigetsu Yoshikawa; Takehira Ya πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 109 KB πŸ‘ 2 views

## BACKGROUND. Pharmacokinetic modulating chemotherapy (PMC) is a new therapeutic concept in combination with continuous 5-fluorouracil (5-FU) infusion and UFT. UFT enhanced plasma 5-FU concentration and antitumor effects during 5-FU infusion. The authors report on their experiences with arterial